<i>Complement factor B</i> (<i>CFB</i>) variants have been described to play a causative role in auto-immune associated C3 glomerulopathy (C3G) and/or atypical hemolytic uremic syndrome (aHUS) by affecting the dysregulations of alternative pathway activation. The gene discussed is CFB; the disease is atypical hemolytic-uremic syndrome.